Teva Pharmaceutical Industries reported higher than expected second-quarter profit, boosted by a jump in sales of its Austedo treatment for Huntington's Disease.
reported higher than expected second-quarter profit, boosted by a jump in sales of its Austedo treatment for Huntington's Disease.
Revenue rose 2% to $3.9 billion, with Austedo sales up 51% in North America to $308 million. Migraine treatment Ajovy's sales rose 16% to $57 million. Sales of generic drugs dipped 6% to $969 million in North America but grew 4% to $909 million in Europe, where Ajovy rose 32%.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Dog stolen from Huntington Station home found wandering streets of NJBandit was found on July 31, wandering the streets about 60 miles away in New Jersey.
Read more »
Customers want instant gratification. Workers say it’s pushing them to the brinkWorkers in vastly different industries — UPS delivery drivers and Hollywood actors and writers — say they're expected to do more with less due to consumer demand for speed and convenience. It's pushing a surge in labor unrest.
Read more »
Customers want instant gratification. Workers say it’s pushing them to the brinkDrastic changes in consumer demands are driving labor unrest in diverse industries upended by technology.
Read more »
San Clemente’s Houshmand secures spot on 2024 World Tour at U.S. Open of SurfingA big moment at the US Open of Surfing in Huntington Beach as Cole Houshmand solidifs his lifelong dream to compete against the world’s best next year.
Read more »
Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus dealShares of Merck are down roughly 4% this year, with a market value of roughly $270 billion, making it the third largest pharmaceutical company based in the U.S.
Read more »